Immunovant, Inc. IMVT Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s other accrued liabilities?
- Immunovant, Inc. (IMVT) reported other accrued liabilities of $175K in Q1 2026.
- What is the long-term trend for Immunovant, Inc.'s other accrued liabilities?
- Over 3 years (2023 to 2026), Immunovant, Inc.'s other accrued liabilities has grown at a -20.6% compound annual growth rate (CAGR), from $350K to $175K.
- What does other accrued liabilities mean?
- This captures miscellaneous short-term obligations that do not fit into standard categories like accounts payable or accrued compensation. It often includes items such as customer deposits, short-term tax provisions, or other minor contractual liabilities. It provides insight into the breadth of the company's short-term financial commitments.